Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Romain Fournier

Chief Editor
Having worked in the British, French and Swiss financial press, Romain is able to report on local and international issues, as comfortable in French as in the language of Shakespeare, Romain Fournier leads the editorial team at Marketscreener. Fine connoisseur of the English-speaking markets, Romain delivers an editorial every day on US and UK markets.

Analyst recommendations: Intel, Roku, GSK...

11/11/2022 | 05:09am EST

Every day, find a selection of analysts' recommendations covering North America and the UK. The list only includes companies that have been the subject of a change of opinion or price target, or of a new coverage. It may be updated during the session. This information is used to shed light on the movements of certain stocks or the market sentiment on a company.

 

Altria: UBS downgrades to Sell from Neutral, adjusts Price Target to $38 from $43

GSK: UBS cut its recommendation to sell from neutral. PT down 4.4% to 1,300 pence.

Intel: J.P. Morgan downgrades to underweight from rating suspended. PT up 7.5% to $32.

M&G: Jefferies initiated coverage with a recommendation of buy. PT set to 235 pence.

Roku: Jefferies initiated coverage with a recommendation of hold. PT set to $45.


ę MarketScreener.com 2022
Stocks mentioned in the article
ChangeLast1st jan.
ALTRIA GROUP, INC. -0.34% 44.14 Delayed Quote.-3.43%
GSK PLC 0.34% 1410 Delayed Quote.-1.92%
INTEL CORPORATION -6.41% 28.16 Delayed Quote.6.55%
M&G PLC 0.19% 208.4 Delayed Quote.10.94%
ROKU, INC. 6.58% 56.04 Delayed Quote.37.69%